Ping Yang, MD, MSCI

Ping's PhD was in pharmacogenetics and he worked on mechanism underlying transcriptional regulation of ion channel genes and the way in which variable transcription affects human electrophysiology. He is currently working in industry as the CEO of Synbio Technologies.